Visionary Holdings Inc. (NASDAQ: GV)

Visionary Holdings Inc. (referred to below as “GV” or the “Company”) was established in Canada in August 2013. Its early operations included education, real estate, and other sectors. In response to shifts in the global industrial landscape, population aging, rapid advances in biotechnology, and the continued maturation of artificial intelligence, the Company has pursued ongoing business upgrades and strategic transformation.

Beginning in 2021, the Company increased its focus on the education sector. On May 17, 2022, it was listed on the Nasdaq Stock Market under the ticker symbol GV, establishing an important platform connecting North American capital markets with international industry resources.

In September 2023, GV initiated a new strategic transformation, progressively shifting its future development priorities toward:

• Biotechnology
• Regenerative medicine and related technologies
• Anti-aging and longevity technologies
• Comprehensive health and health management
  

Beginning in 2025, the Company further advanced industry integration across biotechnology, premium medical aesthetics, anti-aging, and comprehensive health, while continuing to optimize its traditional business portfolio.

In 2026, the Company incorporated AI-powered health data and the international health industry into its core strategy, advancing GV’s transformation from a traditional operating company into a diversified industrial group with:

Biotechnology research and development capabilities, industry integration expertise, international market reach, channel management capabilities, and the ability to coordinate with global capital markets.

I. Overall Strategic Positioning

GV is committed to building an international industrial ecosystem that creates multidimensional synergies across biotechnology, comprehensive health, product supply chains, and international capital.

II. Core Industry Strategy

GV plans to develop four core business segments:

• Segment 1: Biotechnology and Anti-Aging Technologies
• Segment 2: Comprehensive Health and Health Management
• Segment 3: AI-Powered Health and Big Data
• Segment 4: International Health Products and Supply Chains

III. Core Corporate Value

The Company’s four business segments do not operate independently. Together, they form a collaborative ecosystem built on coordinated development and shared resources, creating an integrated industrial value chain spanning:

Technology R&D → Commercial Application → Health Services → Consumer Channels → Data Accumulation → AI Enablement → Industry Investment → International Expansion


Congratulatory messages from all three levels of Canadian goverment.